Alelopharma Inc.

Bloomfield Hills, MI

UEI
WAKKU35UEN73
CAGE
97BC1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
6600 Cathedral Dr, Bloomfield Hills, MI 48301, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Alelopharma Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Ultra-precision diagnostics for ALK+ non-small cell lung cancer - background & significance: identifying ALK-positive… Grant · R43CA298267 National Cancer Institute $399,153

Quick answers

What is Alelopharma Inc.'s UEI?

Alelopharma Inc.'s Unique Entity ID (UEI) in SAM.gov is WAKKU35UEN73.

What is Alelopharma Inc.'s CAGE code?

Alelopharma Inc.'s CAGE code is 97BC1.

What is Alelopharma Inc.'s primary NAICS code?

Alelopharma Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Alelopharma Inc. located?

Alelopharma Inc.'s physical address in SAM.gov is 6600 Cathedral Dr, Bloomfield Hills, MI 48301, USA.

Is Alelopharma Inc. registered in SAM.gov?

Yes. Alelopharma Inc.'s SAM.gov registration is active through July 13, 2027.

What is Alelopharma Inc.'s most recent federal award?

Alelopharma Inc.'s most recent federal grant award is Ultra-precision diagnostics for ALK+ non-small cell lung cancer - background & significance: identifying ALK-positive… (R43CA298267), from National Cancer Institute, on July 9, 2025.

On GovTribe

See Alelopharma Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors